$1.59
-0.04 (-2.45%)
Open$1.62
Previous Close$1.63
Day High$1.65
Day Low$1.58
52W High$2.62
52W Low$0.71
Volume—
Avg Volume1.66M
Market Cap249.90M
P/E Ratio1.49
EPS$1.46
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+2,176.7% upside
Current
$1.59
$1.59
Target
$36.20
$36.20
$24.75
$36.20 avg
$54.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.58M | 96.77M | 45.49M |
| Net Income | 225.43M | 346.99M | -11,017,037 |
| Profit Margin | 398.4% | 378.5% | -24.2% |
| EBITDA | -245,263,755 | -398,495,924 | -13,211,435 |
| Free Cash Flow | — | — | -11,236,120 |
| Rev Growth | -41.5% | -41.5% | +9.2% |
| Debt/Equity | 0.84 | 0.84 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |